Huons Co., Ltd. (243070.KQ)

KRW 28400.0

(1.79%)

Operating Expenses Summary of Huons Co., Ltd.

Huons Co., Ltd.'s latest annual operating expenses in 2023 was 226.14 Billion KRW , up 1.21% from previous year.
Huons Co., Ltd.'s latest quarterly operating expenses in 2024 Q1 was 62.43 Billion KRW , up 7.12% from previous quarter.
Huons Co., Ltd. reported a annual operating expenses of 225.05 Billion KRW in annual operating expenses 2022, up 12.67% from previous year.
Huons Co., Ltd. reported a annual operating expenses of 199.74 Billion KRW in annual operating expenses 2021, up 22.22% from previous year.
Huons Co., Ltd. reported a quarterly operating expenses of 62.05 Billion KRW for 2024 Q2, down -0.61% from previous quarter.
Huons Co., Ltd. reported a quarterly operating expenses of 56.27 Billion KRW for 2023 Q2, up 0.05% from previous quarter.

Annual Operating Expenses Chart of Huons Co., Ltd. (2023 - 2014)

Historical Annual Operating Expenses of Huons Co., Ltd. (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	226.14 Billion KRW	1.21%
2022	225.05 Billion KRW	12.67%
2021	199.74 Billion KRW	22.22%
2020	163.43 Billion KRW	9.03%
2019	149.89 Billion KRW	10.67%
2018	135.44 Billion KRW	13.32%
2017	119.51 Billion KRW	76.63%
2016	67.66 Billion KRW	0.0%
2014	64.34 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	62.43 Billion KRW	7.12%
2024 Q2	62.05 Billion KRW	-0.61%
2023 Q2	56.27 Billion KRW	0.05%
2023 FY	227.76 Billion KRW	1.21%
2023 Q4	58.29 Billion KRW	6.35%
2023 Q1	56.25 Billion KRW	5.16%
2023 Q3	54.8 Billion KRW	-2.61%
2022 Q2	54.98 Billion KRW	3.87%
2022 Q4	53.49 Billion KRW	-14.47%
2022 Q3	62.54 Billion KRW	13.74%
2022 Q1	52.93 Billion KRW	-8.73%
2022 FY	225.05 Billion KRW	12.67%
2021 Q2	51.06 Billion KRW	20.26%
2021 FY	199.74 Billion KRW	22.22%
2021 Q1	42.46 Billion KRW	62.62%
2021 Q4	58 Billion KRW	19.08%
2021 Q3	48.7 Billion KRW	-4.62%
2020 Q3	41.6 Billion KRW	0.44%
2020 Q1	37.9 Billion KRW	-11.65%
2020 Q2	41.42 Billion KRW	9.29%
2020 FY	163.43 Billion KRW	9.03%
2020 Q4	26.11 Billion KRW	-37.24%
2019 Q2	36.58 Billion KRW	5.92%
2019 FY	149.89 Billion KRW	10.67%
2019 Q4	42.9 Billion KRW	14.62%
2019 Q3	37.42 Billion KRW	2.31%
2019 Q1	34.53 Billion KRW	11.52%
2018 FY	135.44 Billion KRW	13.32%
2018 Q2	32.33 Billion KRW	6.34%
2018 Q3	30.81 Billion KRW	-4.72%
2018 Q1	30.41 Billion KRW	1.04%
2018 Q4	30.97 Billion KRW	0.52%
2017 Q1	22.57 Billion KRW	-64.24%
2017 FY	119.51 Billion KRW	76.63%
2017 Q4	30.09 Billion KRW	9.71%
2017 Q3	27.43 Billion KRW	-6.92%
2017 Q2	29.47 Billion KRW	30.53%
2016 Q3	21.66 Billion KRW	0.0%
2016 FY	67.66 Billion KRW	0.0%
2016 Q4	63.14 Billion KRW	191.42%
2014 FY	64.34 Billion KRW	0.0%

Peer Operating Expenses Comparison of Huons Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
HLB Pharmaceutical Co., Ltd	102.52 Billion KRW	-120.57%
CMG Pharmaceutical Co., Ltd.	37.86 Billion KRW	-497.216%
Celltrion Pharm, Inc.	80.93 Billion KRW	-179.41%
Huons Global Co., Ltd.	294.87 Billion KRW	23.309%
DongKook Pharmaceutical Co., Ltd.	338.16 Billion KRW	33.127%
Enzychem Lifesciences Corporation	18.7 Billion KRW	-1109.055%
Humedix Co., Ltd.	33.04 Billion KRW	-584.384%
Boditech Med Inc.	47.05 Billion KRW	-380.628%
EuBiologics Co., Ltd.	24.95 Billion KRW	-806.03%
FutureChem Co.,Ltd	9.16 Billion KRW	-2367.171%
BNC Korea Co., Ltd.	25.19 Billion KRW	-797.437%
AptaBio Therapeutics Inc.	16.45 Billion KRW	-1274.572%